APA (7th ed.) Citation

YH, C., YC, C., WJ, W., M, C., CC, Y., YW, L., . . . CM, C. (2026). Retraction notice to "Kefir peptides mitigate L-NAME-induced preeclampsia in rats through modulating hypertension and endothelial dysfunction" [Biomedicine & Pharmacotherapy 180 (2024) 117592]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 198, 119232. https://doi.org/10.1016/j.biopha.2026.119232

Chicago Style (17th ed.) Citation

YH, Chen, Chang YC, Wu WJ, Chen M, Yen CC, Lan YW, Cheng HC, and Chen CM. "Retraction Notice to "Kefir Peptides Mitigate L-NAME-induced Preeclampsia in Rats Through Modulating Hypertension and Endothelial Dysfunction" [Biomedicine & Pharmacotherapy 180 (2024) 117592]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 198 (2026): 119232. https://doi.org/10.1016/j.biopha.2026.119232.

MLA (9th ed.) Citation

YH, Chen, et al. "Retraction Notice to "Kefir Peptides Mitigate L-NAME-induced Preeclampsia in Rats Through Modulating Hypertension and Endothelial Dysfunction" [Biomedicine & Pharmacotherapy 180 (2024) 117592]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 198, 2026, p. 119232, https://doi.org/10.1016/j.biopha.2026.119232.